This stock has not event started to run....
https://www.livewiremarkets.com/wires/desk-note-invex-therapeutics-ixc-ixc-post-placement-indigestion-an-opportunity-mkt-cap-f-diluted-a-131-2m-1-455
Both IXC and PAR (Paradigm Biopharmaceuticals) are repurposing existing drugs, successfully completed Phase II trials, completed recent capital raises.
IXC does not have the profile of PAR which may be on the cusp of an ASX300 inclusion. It was floated out of the West, better known for resource deals, has a smaller market cap, and less liquidity than PAR. But perhaps that is the opportunity? There are a number of reasons to take a closer look at IXC....
Read the article. It's a good one.
- Forums
- ASX - By Stock
- There is more for the market to discover in the IXC story
This stock has not event started to...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
|
|||||
Last
7.1¢ |
Change
0.001(1.43%) |
Mkt cap ! $5.335M |
Open | High | Low | Value | Volume |
7.1¢ | 7.3¢ | 7.1¢ | $2.546K | 35.86K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14158 | 7.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14158 | 0.071 |
1 | 62163 | 0.070 |
1 | 100000 | 0.063 |
1 | 100000 | 0.062 |
1 | 100000 | 0.061 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 5000 | 1 |
0.083 | 4000 | 1 |
0.085 | 1000 | 1 |
0.090 | 126146 | 1 |
0.095 | 100000 | 1 |
Last trade - 14.37pm 31/07/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online